Eishi Baba

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 165 publications

Efficacy of Pazopanib for a Patient with FGFR1-Amplified Breast Cancer: A Case Report.

Efficacy of Pazopanib for a Patient with FGFR1-Amplified Breast Cancer: A Case Report.

Journal: Case reports in oncology

Published: February 20, 2026

Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer.

Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer.

Journal: BMC cancer

Published: October 28, 2025

Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).

Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 14, 2025

Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan.

Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan.

Journal: EClinicalMedicine

Published: October 11, 2025

Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Journal: Japanese journal of clinical oncology

Published: September 04, 2025

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors.

Journal: Japanese journal of clinical oncology

Published: August 14, 2025

Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.

Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: June 30, 2025

Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.

Metastatic urachal carcinoma treated with trifluridine/tipiracil and bevacizumab: a case report.

Journal: International cancer conference journal

Published: February 12, 2025

Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022.

Journal: International journal of clinical oncology

Published: January 17, 2025

Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis.

Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 20, 2024

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab.

Journal: Internal medicine (Tokyo, Japan)

Published: October 20, 2024

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes.

Efficacy of pembrolizumab in microsatellite-stable, tumor mutational burden-high metastatic colorectal cancer: genomic signatures and clinical outcomes.

Journal: ESMO open

Published: September 10, 2024

Showing 1-12 of 165

Last Updated: 09/26/2026